Shandong Jincheng Pharmaceutical Group Co., Ltd (SHE:300233)

SHE:300233 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	853.68	917.67	1,025	859.13	981.18	1,075
Cash & Short-Term Investments	853.68	917.67	1,025	859.13	981.18	1,075
Cash Growth	-19.05%	-10.44%	19.27%	-12.44%	-8.75%	8.56%
Accounts Receivable	689.45	696.8	794.56	803.39	684	790.05
Other Receivables	4.26	6.45	7.81	4.62	5.08	2.07
Receivables	693.71	703.25	802.37	808.01	689.08	792.12
Inventory	596.36	598.86	501.28	579.22	391.32	284.08
Prepaid Expenses	-	-	0.2	0.55	0.01	1.37
Other Current Assets	40.51	38.5	40.77	61.24	77.68	69.04
Total Current Assets	2,184	2,258	2,369	2,308	2,139	2,222
Property, Plant & Equipment	2,259	2,310	2,468	2,469	2,093	1,777
Long-Term Investments	183.7	183.28	147.52	141.22	143.31	129.39
Other Intangible Assets	495.34	513.51	547.29	452.2	449.75	494.35
Long-Term Deferred Tax Assets	60.16	63.94	69.77	51.96	30.71	40.93
Long-Term Deferred Charges	264.18	252.96	310.89	369.59	329.72	286.79
Other Long-Term Assets	24.91	23.5	3.51	34.42	89.77	49.8
Total Assets	5,471	5,605	5,916	5,826	5,275	5,000
Accounts Payable	529.2	552.56	824	726.05	515.31	299.63
Accrued Expenses	153.14	355.9	402.32	394.98	362.19	400.69
Short-Term Debt	101.08	55.04	94	212.89	223	154
Current Portion of Long-Term Debt	51.5	101.52	109.24	163.2	155.45	-
Current Portion of Leases	-	0.13	0.72	1.11	2.37	-
Current Income Taxes Payable	38.88	21.53	24.85	18.84	18.72	18.83
Current Unearned Revenue	41.62	50.94	32.74	44.67	54.47	35.03
Other Current Liabilities	207.47	93.35	112.47	139.2	84.94	240.73
Total Current Liabilities	1,123	1,231	1,600	1,701	1,416	1,149
Long-Term Debt	351.76	351.99	346.7	271.69	208.29	255.39
Long-Term Leases	6.03	6.88	3.46	2.02	63.52	-
Long-Term Unearned Revenue	51.43	53.88	61.6	66	54.81	51.41
Long-Term Deferred Tax Liabilities	125.85	129.1	122.94	126.21	92.66	77.11
Total Liabilities	1,658	1,773	2,135	2,167	1,836	1,533
Common Stock	383.87	383.87	383.87	387.41	387.41	391.55
Additional Paid-In Capital	2,328	2,328	2,328	2,397	2,404	2,474
Retained Earnings	1,029	1,051	967.95	850.41	653.34	622.84
Treasury Stock	-55.01	-55.01	-	-56.94	-80.01	-73.55
Comprehensive Income & Other	61.37	59.49	34.62	29.33	29.44	23.45
Total Common Equity	3,747	3,767	3,714	3,607	3,394	3,438
Minority Interest	66.42	65.17	66.93	51.87	44.96	29.32
Shareholders' Equity	3,813	3,832	3,781	3,659	3,439	3,467
Total Liabilities & Equity	5,471	5,605	5,916	5,826	5,275	5,000
Total Debt	510.37	515.56	554.12	650.91	652.62	409.39
Net Cash (Debt)	343.31	402.11	470.54	208.22	328.55	665.85
Net Cash Growth	-17.03%	-14.54%	125.98%	-36.62%	-50.66%	80.04%
Net Cash Per Share	0.90	1.06	1.21	0.54	0.85	1.72
Filing Date Shares Outstanding	379.33	379.33	383.87	383.1	383.87	387.41
Total Common Shares Outstanding	379.33	379.33	383.87	383.1	383.87	387.41
Working Capital	1,061	1,027	768.95	607.21	722.83	1,073
Book Value Per Share	9.88	9.93	9.68	9.42	8.84	8.87
Tangible Book Value	3,252	3,253	3,167	3,155	2,945	2,944
Tangible Book Value Per Share	8.57	8.58	8.25	8.24	7.67	7.60
Buildings	-	1,424	1,406	1,356	1,021	946.46
Machinery	-	2,414	2,289	2,152	1,671	1,388
Construction In Progress	-	73.33	148.97	121.31	332.32	300.44

Updated Oct 24, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.